Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Endocrinol Metab ; 102(11): 4013-4022, 2017 11 01.
Article in English | MEDLINE | ID: mdl-28973655

ABSTRACT

Context: The co-occurrence of pheochromocytoma (PC) and renal tumors was linked to the inherited familial cancer syndrome von Hippel-Lindau (VHL) disease more than six decades ago. Subsequently, other shared genetic causes of predisposition to renal tumors and to PC, paraganglioma (PGL), or head and neck paraganglioma (HNPGL) have been described, but case series of non-VHL-related cases of renal tumor and pheochromocytoma/paraganglioma tumor association syndrome (RAPTAS) are rare. Objective: To determine the clinical and molecular features of non-VHL RAPTAS by literature review and characterization of a case series. Design: A review of the literature was performed and a retrospective study of referrals for investigation of genetic causes of RAPTAS. Results: Literature review revealed evidence of an association, in addition to VHL disease, between germline mutations in SDHB, SDHC, SDHD, TMEM127, and MAX genes and RAPTAS [defined here as the co-occurrence of tumors from both classes (PC/PGL/HNPGL and renal tumors) in the same individual or in first-degree relatives]. In both the literature review and our case series of 22 probands with non-VHL RAPTAS, SDHB mutations were the most frequent cause of non-VHL RAPTAS. A genetic cause was identified in 36.3% (8/22) of kindreds. Conclusion: Renal tumors and PC/PGL/HNPGL tumors share common molecular features and their co-occurrence in an individual or family should prompt genetic investigations. We report a case of MAX-associated renal cell carcinoma and confirm the role of TMEM127 mutations with renal cell carcinoma predisposition.


Subject(s)
Adrenal Gland Neoplasms/genetics , Kidney Neoplasms/genetics , Paraganglioma/genetics , Pheochromocytoma/genetics , Adrenal Gland Neoplasms/pathology , Adult , Aged , Child , Cohort Studies , Female , Genetic Predisposition to Disease , Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/pathology , Humans , Kidney Neoplasms/pathology , Male , Middle Aged , Mutation , Paraganglioma/pathology , Pheochromocytoma/pathology , Retrospective Studies , Syndrome , Young Adult , von Hippel-Lindau Disease/genetics , von Hippel-Lindau Disease/pathology
2.
Proc Natl Acad Sci U S A ; 99(10): 6806-11, 2002 May 14.
Article in English | MEDLINE | ID: mdl-12011441

ABSTRACT

CTCF, a conserved, ubiquitous, and highly versatile 11-zinc-finger factor involved in various aspects of gene regulation, forms methylation-sensitive insulators that regulate X chromosome inactivation and expression of imprinted genes. We document here the existence of a paralogous gene with the same exons encoding the 11-zinc-finger domain as mammalian CTCF genes and thus the same DNA-binding potential, but with distinct amino and carboxy termini. We named this gene BORIS for Brother of the Regulator of Imprinted Sites. BORIS is present only in the testis, and expressed in a mutually exclusive manner with CTCF during male germ cell development. We show here that erasure of methylation marks during male germ-line development is associated with dramatic up-regulation of BORIS and down-regulation of CTCF expression. Because BORIS bears the same DNA-binding domain that CTCF employs for recognition of methylation marks in soma, BORIS is a candidate protein for the elusive epigenetic reprogramming factor acting in the male germ line.


Subject(s)
DNA-Binding Proteins/genetics , Genomic Imprinting , Repressor Proteins , Testis/metabolism , Transcription Factors/genetics , Zinc Fingers , Amino Acid Sequence , Animals , CCCTC-Binding Factor , Cloning, Molecular , DNA Methylation , Gene Expression , Genetic Markers , Humans , Male , Mice , Molecular Sequence Data , Protein Structure, Tertiary , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...